Histomorphometric comparison of cardiac allograft vasculopathy in miniature swine

Stuart L. Houser, Isabel M. McMorrow, Christian Leguern, Margaret L. Schwarze, Yasuli Fuchimoto, David H. Sachs, Joren C. Madsen

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Whether the pathologic characteristics of vascular lesions manifested in recipients with cardiac allograft vasculopathy (CAV) differ with the severity of the histocompatibility barrier crossed at transplantation or with the type or amount of immunosuppression used to prolong graft survival is unclear. We used miniature swine to determine whether a wide variance in heart transplantation protocols, both in histoincompatibility and immunosuppression, affects the histomorphometry of CAV. Methods: We compared explanted hearts from major histocompatibility complex Class I-disparate recipients who were treated for 12 days with cyclosporine (Group 1) with minor-antigen-disparate hearts transplanted into mixed chimeric recipients previously engrafted with donor hematopoietic progenitor cells (Group 2). We analyzed coronary intimal lesions using computerized morphometry, immunohistochemistry, and TUNEL assay. Myocardial cytokine-gene expression was determined using RNAse protection assays and reverse-transcriptase polymerase chain reaction. Results: The prevalence of CAV in Group 2 was significantly less than that observed in Group 1, but the severity of the lesions in both groups was similar. The vascular lesions that developed in both groups demonstrated the presence of α-smooth-muscle-actin-positive spindle cells expanding the intima, with few inflammatory cells. We noted an absence of proliferating cell nuclear antigen activity and TUNEL-positive cells in both groups. We observed prominent myocardial interferon-γ gene expression only in Group 1. Conclusion: Despite differences in myocardial interferon-γ gene expression, the histology and severity of the vascular lesions in CAV did not vary significantly with different histoincompatibilities or treatment protocols. These results suggest that the origin of CAV cannot be determined by histology alone.

Original languageEnglish
Pages (from-to)50-60
Number of pages11
JournalJournal of Heart and Lung Transplantation
Volume23
Issue number1
DOIs
Publication statusPublished - 2004 Jan
Externally publishedYes

Fingerprint

Miniature Swine
Allografts
Blood Vessels
In Situ Nick-End Labeling
Gene Expression
Immunosuppression
Interferons
Histology
Tunica Intima
Histocompatibility
Proliferating Cell Nuclear Antigen
Graft Survival
Heart Transplantation
Clinical Protocols
Hematopoietic Stem Cells
Major Histocompatibility Complex
Reverse Transcriptase Polymerase Chain Reaction
Cyclosporine
Smooth Muscle
Actins

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Transplantation

Cite this

Houser, S. L., McMorrow, I. M., Leguern, C., Schwarze, M. L., Fuchimoto, Y., Sachs, D. H., & Madsen, J. C. (2004). Histomorphometric comparison of cardiac allograft vasculopathy in miniature swine. Journal of Heart and Lung Transplantation, 23(1), 50-60. https://doi.org/10.1016/S1053-2498(03)00065-2

Histomorphometric comparison of cardiac allograft vasculopathy in miniature swine. / Houser, Stuart L.; McMorrow, Isabel M.; Leguern, Christian; Schwarze, Margaret L.; Fuchimoto, Yasuli; Sachs, David H.; Madsen, Joren C.

In: Journal of Heart and Lung Transplantation, Vol. 23, No. 1, 01.2004, p. 50-60.

Research output: Contribution to journalArticle

Houser, SL, McMorrow, IM, Leguern, C, Schwarze, ML, Fuchimoto, Y, Sachs, DH & Madsen, JC 2004, 'Histomorphometric comparison of cardiac allograft vasculopathy in miniature swine', Journal of Heart and Lung Transplantation, vol. 23, no. 1, pp. 50-60. https://doi.org/10.1016/S1053-2498(03)00065-2
Houser, Stuart L. ; McMorrow, Isabel M. ; Leguern, Christian ; Schwarze, Margaret L. ; Fuchimoto, Yasuli ; Sachs, David H. ; Madsen, Joren C. / Histomorphometric comparison of cardiac allograft vasculopathy in miniature swine. In: Journal of Heart and Lung Transplantation. 2004 ; Vol. 23, No. 1. pp. 50-60.
@article{088a43dbaaa0465fab49d07950c51e22,
title = "Histomorphometric comparison of cardiac allograft vasculopathy in miniature swine",
abstract = "Background: Whether the pathologic characteristics of vascular lesions manifested in recipients with cardiac allograft vasculopathy (CAV) differ with the severity of the histocompatibility barrier crossed at transplantation or with the type or amount of immunosuppression used to prolong graft survival is unclear. We used miniature swine to determine whether a wide variance in heart transplantation protocols, both in histoincompatibility and immunosuppression, affects the histomorphometry of CAV. Methods: We compared explanted hearts from major histocompatibility complex Class I-disparate recipients who were treated for 12 days with cyclosporine (Group 1) with minor-antigen-disparate hearts transplanted into mixed chimeric recipients previously engrafted with donor hematopoietic progenitor cells (Group 2). We analyzed coronary intimal lesions using computerized morphometry, immunohistochemistry, and TUNEL assay. Myocardial cytokine-gene expression was determined using RNAse protection assays and reverse-transcriptase polymerase chain reaction. Results: The prevalence of CAV in Group 2 was significantly less than that observed in Group 1, but the severity of the lesions in both groups was similar. The vascular lesions that developed in both groups demonstrated the presence of α-smooth-muscle-actin-positive spindle cells expanding the intima, with few inflammatory cells. We noted an absence of proliferating cell nuclear antigen activity and TUNEL-positive cells in both groups. We observed prominent myocardial interferon-γ gene expression only in Group 1. Conclusion: Despite differences in myocardial interferon-γ gene expression, the histology and severity of the vascular lesions in CAV did not vary significantly with different histoincompatibilities or treatment protocols. These results suggest that the origin of CAV cannot be determined by histology alone.",
author = "Houser, {Stuart L.} and McMorrow, {Isabel M.} and Christian Leguern and Schwarze, {Margaret L.} and Yasuli Fuchimoto and Sachs, {David H.} and Madsen, {Joren C.}",
year = "2004",
month = "1",
doi = "10.1016/S1053-2498(03)00065-2",
language = "English",
volume = "23",
pages = "50--60",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Histomorphometric comparison of cardiac allograft vasculopathy in miniature swine

AU - Houser, Stuart L.

AU - McMorrow, Isabel M.

AU - Leguern, Christian

AU - Schwarze, Margaret L.

AU - Fuchimoto, Yasuli

AU - Sachs, David H.

AU - Madsen, Joren C.

PY - 2004/1

Y1 - 2004/1

N2 - Background: Whether the pathologic characteristics of vascular lesions manifested in recipients with cardiac allograft vasculopathy (CAV) differ with the severity of the histocompatibility barrier crossed at transplantation or with the type or amount of immunosuppression used to prolong graft survival is unclear. We used miniature swine to determine whether a wide variance in heart transplantation protocols, both in histoincompatibility and immunosuppression, affects the histomorphometry of CAV. Methods: We compared explanted hearts from major histocompatibility complex Class I-disparate recipients who were treated for 12 days with cyclosporine (Group 1) with minor-antigen-disparate hearts transplanted into mixed chimeric recipients previously engrafted with donor hematopoietic progenitor cells (Group 2). We analyzed coronary intimal lesions using computerized morphometry, immunohistochemistry, and TUNEL assay. Myocardial cytokine-gene expression was determined using RNAse protection assays and reverse-transcriptase polymerase chain reaction. Results: The prevalence of CAV in Group 2 was significantly less than that observed in Group 1, but the severity of the lesions in both groups was similar. The vascular lesions that developed in both groups demonstrated the presence of α-smooth-muscle-actin-positive spindle cells expanding the intima, with few inflammatory cells. We noted an absence of proliferating cell nuclear antigen activity and TUNEL-positive cells in both groups. We observed prominent myocardial interferon-γ gene expression only in Group 1. Conclusion: Despite differences in myocardial interferon-γ gene expression, the histology and severity of the vascular lesions in CAV did not vary significantly with different histoincompatibilities or treatment protocols. These results suggest that the origin of CAV cannot be determined by histology alone.

AB - Background: Whether the pathologic characteristics of vascular lesions manifested in recipients with cardiac allograft vasculopathy (CAV) differ with the severity of the histocompatibility barrier crossed at transplantation or with the type or amount of immunosuppression used to prolong graft survival is unclear. We used miniature swine to determine whether a wide variance in heart transplantation protocols, both in histoincompatibility and immunosuppression, affects the histomorphometry of CAV. Methods: We compared explanted hearts from major histocompatibility complex Class I-disparate recipients who were treated for 12 days with cyclosporine (Group 1) with minor-antigen-disparate hearts transplanted into mixed chimeric recipients previously engrafted with donor hematopoietic progenitor cells (Group 2). We analyzed coronary intimal lesions using computerized morphometry, immunohistochemistry, and TUNEL assay. Myocardial cytokine-gene expression was determined using RNAse protection assays and reverse-transcriptase polymerase chain reaction. Results: The prevalence of CAV in Group 2 was significantly less than that observed in Group 1, but the severity of the lesions in both groups was similar. The vascular lesions that developed in both groups demonstrated the presence of α-smooth-muscle-actin-positive spindle cells expanding the intima, with few inflammatory cells. We noted an absence of proliferating cell nuclear antigen activity and TUNEL-positive cells in both groups. We observed prominent myocardial interferon-γ gene expression only in Group 1. Conclusion: Despite differences in myocardial interferon-γ gene expression, the histology and severity of the vascular lesions in CAV did not vary significantly with different histoincompatibilities or treatment protocols. These results suggest that the origin of CAV cannot be determined by histology alone.

UR - http://www.scopus.com/inward/record.url?scp=0346008035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346008035&partnerID=8YFLogxK

U2 - 10.1016/S1053-2498(03)00065-2

DO - 10.1016/S1053-2498(03)00065-2

M3 - Article

C2 - 14734127

AN - SCOPUS:0346008035

VL - 23

SP - 50

EP - 60

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 1

ER -